Contraception
Volume 81, Issue 5 , Pages 441-445, May 2010

Randomized trial of buccal versus vaginal misoprostol for induction of second trimester abortion

Boston University Medical Center, Boston University, Boston, MA 02118, USA

Received 9 July 2009; received in revised form 18 December 2009; accepted 22 December 2009. published online 01 February 2010.

Abstract 

Background

We evaluated the efficacy and acceptability of repeat doses of buccal misoprostol compared to vaginal misoprostol for second trimester pregnancy termination by induction.

Study Design

Women requesting termination of a pregnancy between18 and 22 weeks gestation were approached for participation. All women received 400 mcg misoprostol vaginally on admission. Participants were randomized to receive subsequent doses of 200 mcg misoprostol every 6 h either buccally or vaginally. All participants completed an acceptability survey.

Results

Sixty-four women participated. The mean gestational age was 19.7 weeks. The median time to abortion in the buccal group was 15 h, which was not significantly different (p=0.44) from the vaginal-only group of 12 h. Most women in both groups preferred their allocated administrative route.

Conclusion

Repeat doses of buccal misoprostol are as effective as vaginal misoprostol in inducing abortions in the midtrimester and are highly acceptable to most women. It is reasonable to offer both options to women.

Keywords: Randomized control trial, Induced abortion, Second trimester, Misoprostol, Buccal misoprostol

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0010-7824(09)00556-3

doi:10.1016/j.contraception.2009.12.018

Contraception
Volume 81, Issue 5 , Pages 441-445, May 2010